FABTECH vs NOVARTIND: Stock Comparison
Novartis India Limited is the larger company by market capitalisation. Fabtech Technologies Limited shows a lower P/E, a higher ROE and faster revenue growth, while Novartis India Limited shows a higher dividend yield, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
FABTECH leads 7; NOVARTIND leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | FABTECH | NOVARTIND |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical Equipment & Supplies | Pharmaceuticals |
Price
| Metric | FABTECH | NOVARTIND |
|---|---|---|
| Live Price | ₹147.62 | ₹1,486.3 |
| Day Change | 0.39% | -1.06% |
| Volume | 1.64 L | 6,845 |
| 52-Week High | ₹262.8 | ₹1,780 |
| 52-Week Low | ₹132.7 | ₹950 |
| Distance from 52W High | -43.83% | -16.5% |
Valuation
| Metric | FABTECH | NOVARTIND |
|---|---|---|
| Market Cap | ₹659 Cr | ₹3,664 Cr |
| P/E Ratio | 13.38x | 37.65x |
| P/B Ratio | 1.55x | 4.5x |
| EPS | ₹10.95 | ₹37.76 |
| Book Value | ₹109.44 | ₹331.34 |
| Dividend Yield | 0.41% | 1.7% |
Growth
| Metric | FABTECH | NOVARTIND |
|---|---|---|
| Revenue Growth (TTM YoY) | 17.5% | 8% |
| EPS Growth (TTM YoY) | 23.4% | -13.8% |
| Qtr Sales Growth | 17.5% | 7.95% |
| Qtr Profit Growth | 46.2% | -13.8% |
Profitability & Leverage
| Metric | FABTECH | NOVARTIND |
|---|---|---|
| ROE | 12.5% | 11.6% |
| ROCE | 13.6% | 16.2% |
| Net Margin | 11.28% | 26.3% |
| Operating Margin | 8.52% | 26.6% |
| Debt to Equity | 0.17x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | FABTECH | NOVARTIND |
|---|---|---|
| Promoter Holding | 68.94% | 0% |
| FII Holding | 0.02%▼ 0.06 pp | 0.16%▼ 0.01 pp |
| DII Holding | 2.45%▲ 0.3 pp | 1.36%▲ 0.83 pp |
| Public Holding | 28.58%▼ 0.25 pp | 27.8%▼ 0.81 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Fabtech Technologies Limited and Novartis India Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.